China Medical System Holdings Limited (0867.HK)
HKD 8.5
(-2.41%)
HKD 8.5
(-2.41%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 637.63 Million CNY | 33.62% |
| 2022 | 477.2 Million CNY | 0.98% |
| 2021 | 472.59 Million CNY | 23.97% |
| 2020 | 381.21 Million CNY | -6.35% |
| 2019 | 407.05 Million CNY | -6.35% |
| 2018 | 434.66 Million CNY | -5.59% |
| 2017 | 460.4 Million CNY | -9.55% |
| 2016 | 509 Million CNY | 32.15% |
| 2015 | 385.17 Million CNY | 103.31% |
| 2014 | 189.45 Million CNY | 14.09% |
| 2013 | 166.05 Million CNY | 71.77% |
| 2012 | 96.67 Million CNY | -26.89% |
| 2011 | 132.23 Million CNY | 24.78% |
| 2010 | 105.97 Million CNY | 40.33% |
| 2009 | 75.51 Million CNY | 86.15% |
| 2008 | 40.56 Million CNY | -47.99% |
| 2007 | 77.99 Million CNY | 493.99% |
| 2006 | 13.13 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 638.49 Million CNY | 0.0% |
| 2024 Q1 | 638.49 Million CNY | 0.13% |
| 2023 Q4 | 637.63 Million CNY | 0.0% |
| 2023 Q2 | 616.44 Million CNY | 0.0% |
| 2023 FY | 637.63 Million CNY | 33.62% |
| 2023 Q1 | 616.44 Million CNY | 29.18% |
| 2023 Q3 | 637.63 Million CNY | 3.44% |
| 2022 FY | 477.2 Million CNY | 0.98% |
| 2022 Q4 | 477.2 Million CNY | 0.0% |
| 2022 Q3 | 477.2 Million CNY | -19.18% |
| 2022 Q2 | 590.45 Million CNY | 0.0% |
| 2022 Q1 | 590.45 Million CNY | 24.94% |
| 2021 Q3 | 472.59 Million CNY | 17.71% |
| 2021 Q4 | 472.59 Million CNY | 0.0% |
| 2021 Q2 | 401.5 Million CNY | 0.0% |
| 2021 FY | 472.59 Million CNY | 23.97% |
| 2021 Q1 | 401.5 Million CNY | 5.32% |
| 2020 Q3 | 381.21 Million CNY | -11.4% |
| 2020 Q2 | 430.27 Million CNY | 0.0% |
| 2020 Q1 | 430.27 Million CNY | 5.7% |
| 2020 Q4 | 381.21 Million CNY | 0.0% |
| 2020 FY | 381.21 Million CNY | -6.35% |
| 2019 Q2 | 429.81 Million CNY | 0.0% |
| 2019 Q1 | 429.81 Million CNY | -1.12% |
| 2019 FY | 407.05 Million CNY | -6.35% |
| 2019 Q4 | 407.05 Million CNY | 0.0% |
| 2019 Q3 | 407.05 Million CNY | -5.29% |
| 2018 Q1 | 416.47 Million CNY | -9.54% |
| 2018 Q2 | 416.47 Million CNY | 0.0% |
| 2018 Q3 | 434.66 Million CNY | 4.37% |
| 2018 Q4 | 434.66 Million CNY | 0.0% |
| 2018 FY | 434.66 Million CNY | -5.59% |
| 2017 Q1 | 458.54 Million CNY | -9.91% |
| 2017 Q4 | 460.4 Million CNY | 0.0% |
| 2017 Q3 | 460.4 Million CNY | 0.41% |
| 2017 Q2 | 458.54 Million CNY | 0.0% |
| 2017 FY | 460.4 Million CNY | -9.55% |
| 2016 Q3 | 509 Million CNY | 28.59% |
| 2016 Q2 | 395.82 Million CNY | 0.0% |
| 2016 FY | 509 Million CNY | 32.15% |
| 2016 Q1 | 395.82 Million CNY | 2.76% |
| 2016 Q4 | 509 Million CNY | 0.0% |
| 2015 Q4 | 385.17 Million CNY | -8.35% |
| 2015 FY | 385.17 Million CNY | 103.31% |
| 2015 Q3 | 420.27 Million CNY | 0.24% |
| 2015 Q2 | 419.27 Million CNY | 0.0% |
| 2015 Q1 | 419.27 Million CNY | 121.31% |
| 2014 FY | 189.45 Million CNY | 14.09% |
| 2014 Q4 | 189.45 Million CNY | 0.0% |
| 2014 Q3 | 189.45 Million CNY | -15.66% |
| 2014 Q2 | 224.62 Million CNY | -22.37% |
| 2014 Q1 | 289.35 Million CNY | 74.25% |
| 2013 Q4 | 166.05 Million CNY | -0.6% |
| 2013 FY | 166.05 Million CNY | 71.77% |
| 2013 Q1 | 184.51 Million CNY | 90.87% |
| 2013 Q2 | 152.91 Million CNY | -17.13% |
| 2013 Q3 | 167.06 Million CNY | 9.25% |
| 2012 Q2 | 105.38 Million CNY | -42.63% |
| 2012 Q4 | 96.67 Million CNY | -0.73% |
| 2012 Q3 | 97.37 Million CNY | -7.6% |
| 2012 FY | 96.67 Million CNY | -26.89% |
| 2012 Q1 | 183.7 Million CNY | 38.92% |
| 2011 FY | 132.23 Million CNY | 24.78% |
| 2011 Q4 | 132.23 Million CNY | 0.0% |
| 2011 Q2 | 113.54 Million CNY | 0.0% |
| 2010 Q2 | 118.73 Million CNY | 0.0% |
| 2010 FY | 105.97 Million CNY | 40.33% |
| 2010 Q4 | 105.97 Million CNY | 0.0% |
| 2009 Q4 | 75.51 Million CNY | 0.0% |
| 2009 FY | 75.51 Million CNY | 86.15% |
| 2008 FY | 40.56 Million CNY | -47.99% |
| 2007 FY | 77.99 Million CNY | 493.99% |
| 2006 FY | 13.13 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -5127.811% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 54.082% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -8676.82% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | -106.959% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | -47.674% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | -113.896% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -914.99% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -548.888% |
| PuraPharm Corporation Limited | 175.59 Million HKD | -263.125% |
| SSY Group Limited | 1.08 Billion HKD | 41.301% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -596.223% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | -100.605% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 98.183% |